Abstract
Ferritin, which was only discovered in the last century, has stirred a formidable debate. Ferritin has long been appreciated as a non-specific acute-phase reactant. Several years ago, we hypothesized the contributory role of ferritin as a pathogenic molecule rather than being a product of inflammation. The latest emerging evidence provides support to this notion. Such revelation provides a step forward towards the understanding of disease conditions associated with hyperferritinaemia, and hence provide new targets for treatment modalities.
Original language | English |
---|---|
Pages (from-to) | 149-150 |
Number of pages | 2 |
Journal | Clinical and Experimental Immunology |
Volume | 191 |
Issue number | 2 |
DOIs |
|
State | Published - 2018 |
Keywords
- acute phase reactant
- ferritin
- hyperferritenemic syndrome
- macrophage activating syndrome
- pro-inflammation